Tara Bancroft
Stock Analyst at TD Cowen
(2.69)
# 1,850
Out of 5,180 analysts
11
Total ratings
66.67%
Success rate
16.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics | Maintains: Buy | $90 → $100 | $99.87 | +0.13% | 2 | Feb 26, 2026 | |
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $21.42 | +58.73% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $7.40 | +170.27% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $73.09 | +9.45% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $31.51 | +58.68% | 1 | Oct 29, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.41 | +609.22% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $4.34 | - | 1 | Aug 31, 2022 |
Protagonist Therapeutics
Feb 26, 2026
Maintains: Buy
Price Target: $90 → $100
Current: $99.87
Upside: +0.13%
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $21.42
Upside: +58.73%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $7.40
Upside: +170.27%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $73.09
Upside: +9.45%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $31.51
Upside: +58.68%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.41
Upside: +609.22%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $4.34
Upside: -